istock-515912196cbarnesphotography

cbarnesphotography / iStockphoto.com

15 January 2018Americas

US identifies shortcomings in China’s IP pharma sector

The US Department of Commerce (DOC) has said that there are “shortcomings” in China’s IP rights when it comes to the country’s pharmaceutical sector.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Trump shuts down manufacturing council following resignations

17 August 2017 US President Donald Trump has put an end to his manufacturing council after a series of resignations.

LSPN 2016: Trump’s TPP announcement is a ‘detriment’ to US companies

8 December 2016 President-elect Donald Trump’s announcement that he will withdraw the US from the Trans-Pacific Partnership is a “detriment” to US companies in terms of enforcing their patent rights in other jurisdictions.

More on this story

Trump shuts down manufacturing council following resignations

17 August 2017 US President Donald Trump has put an end to his manufacturing council after a series of resignations.

LSPN 2016: Trump’s TPP announcement is a ‘detriment’ to US companies

8 December 2016 President-elect Donald Trump’s announcement that he will withdraw the US from the Trans-Pacific Partnership is a “detriment” to US companies in terms of enforcing their patent rights in other jurisdictions.

More on this story

Trump shuts down manufacturing council following resignations

17 August 2017 US President Donald Trump has put an end to his manufacturing council after a series of resignations.

LSPN 2016: Trump’s TPP announcement is a ‘detriment’ to US companies

8 December 2016 President-elect Donald Trump’s announcement that he will withdraw the US from the Trans-Pacific Partnership is a “detriment” to US companies in terms of enforcing their patent rights in other jurisdictions.

More features

Gilead awarded $30m over counterfeit HIV drug scheme

EPO invalidates human milk patent after Nestle opposition

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic